PNTG News & Events

Sees FY26 revenue $1.13B-$1.17B, consensus $1.15B. Sees FY26 adjusted EBITDA $88.5M-$94.1M. Lynette Walbom, the company's CFO, also stated, "We believe providing updated annual adjusted consolidated EBITDA guidance in addition to updated annual revenue and adjusted earnings per share guidance is helpful to understanding our expectations for our business and operational cash flow. This updated guidance reflects management's expectations based on 2025 performance and current operating conditions as well as the impacts of the transaction with UnitedHealth and Amedisys. Our guidance includes revenue in the range of $191.2 to $200.3 million, adjusted EBITDA in the range of $16.7 to $17.9 million, and adjusted EBITDA prior to NCI of $19.8 to $21.1 million relating to these former UnitedHealth and Amedisys assets."

Reports Q4 revenue $289.32M, consensus $275.2M. "2025 was a year of record-breaking performance and growth for Pennant," said Brent Guerisoli, the company's CEO. "Our operational flywheel continues to gain momentum, even in the midst of accelerative expansion. Our growth wasn't only significant in its magnitude--it was strategic, high-quality investment. We added attractive operations to our footprint and created a foundation for additional expansion in the Southeast. At the same time, we drove strong same-store results and continued to execute in our senior living business."